Cetuximab, Encorafenib, Fluorouracil, and Oxaliplatin
About
Membership operator: AND
Therapies: 4
Therapies
Cetuximab (tx:ncit:C1723)
Encorafenib (tx:ncit:C98283)
Fluorouracil (tx:ncit:C505)
Oxaliplatin (tx:ncit:C1181)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy group.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (2) FDA (2) | BRAF p.V600E | Colorectal Adenocarcinoma | Cetuximab, Encorafenib, Fluorouracil, Oxaliplatin |